Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 95.09 million as of March 6, 2026. Its market cap has increased by 276.44% in one year.

Market Cap

95.09M

Enterprise Value

106.94M

Revenue

30.29M

Ranking

n/a

PE Ratio

n/a

Stock Price

8.90

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 95.09M, a decrease of -43.99%. That is a compound annual growth rate of -5.62%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	95.09M	-9.08%
Dec 31, 2025	104.59M	395.31%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Venture Life Group	84.70M
ECO Animal Health Group	67.76M
Animalcare Group	186.42M
Provexis	30.26M
Allergy Therapeutics	696.58M
HUTCHMED (China)	1.77B
N4 Pharma	4.37M
Hikma Pharmaceuticals	2.75B

Market Cap Rankings